Alabama’s long-running medical cannabis licensing saga reaches a significant milestone as formal evidentiary hearings for integrated facility licences open in Tuscaloosa on Monday, July 27, 2026.
The Alabama Medical Cannabis Commission’s designated hearing officer, the Hon. Bernard Harwood, a former Alabama Supreme Court associate justice, will preside over the proceedings starting at 9 a.m.
The hearings will take place at the University of Alabama’s USC Community Safe Room in Tuscaloosa, marking the beginning of an elaborate contested-case process rather than a final licensing decision.
This is not a commission meeting or a vote, but an evidentiary proceeding conducted under the Alabama Administrative Procedure Act, involving testimony, exhibits, and cross-examination from multiple applicants.
Harwood will eventually issue a recommended order identifying the most suitable applicants, after which parties may file exceptions before the full commission considers the matter at a separately noticed public meeting.
Alabama’s medical cannabis law permits the commission to issue up to five integrated facility licences, widely regarded as the most valuable category in the state’s cannabis licensing framework.
Each integrated facility licence authorises cultivation, processing, and dispensing operations, with up to five dispensing sites per licensee, as well as the ability to sell products to other dispensaries across the state.
With five licences potentially on the table, the outcome of these hearings could determine the location and operation of as many as 25 additional retail dispensing sites across Alabama.
The road to this point has been anything but straightforward, with years of litigation in Montgomery County Circuit Court, injunctions from Judge James Anderson, and an appeal to the Alabama Court of Civil Appeals reshaping the entire process.
The appeals court ultimately ruled that licensing disputes of this nature belong within the administrative procedure act’s contested-case hearing process, rather than in circuit court, paving the way for Harwood’s appointment as hearing officer.
Alabama’s first medical cannabis dispensary opened its doors on June 4, 2026, more than five years after the Legislature enacted the current medical cannabis regime, illustrating just how protracted the rollout has been.
The integrated facility hearings are scheduled across 14 trial dates over three weeks, with an estimated nine hours per day dedicated to each of the 14 applicants seeking one of the coveted licences.
Following the conclusion of hearings, Harwood will produce a written recommendation, parties will be given the opportunity to file exceptions, and the commission will then act at a public meeting to determine the final outcome.
Given the state’s established track record of litigation at each stage of the process, further legal challenges following the commission’s eventual vote remain a realistic possibility for all parties involved.
Patients and investors will be watching closely, as the downstream effect on retail access across Alabama hinges directly on how these five integrated facility licences are ultimately awarded.